Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Targeting of a novel fusion protein containing methioninase to the urokinase receptor to inhibit breast cancer cell migration and proliferation.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting of a novel fusion protein containing methioninase to the urokinase receptor to inhibit breast cancer cell migration and proliferation.
Targeting of a novel fusion protein containing methioninase to the urokinase receptor to inhibit breast cancer cell migration and proliferation. Cancer Chemother Pharmacol. 2003 Oct; 52(4):270-6.
View in:
PubMed
subject areas
Breast Neoplasms
Breast Neoplasms
Carbon-Sulfur Lyases
Carbon-Sulfur Lyases
Cell Division
Cell Division
Cell Line, Tumor
Cell Line, Tumor
Cell Movement
Cell Movement
Cell Survival
Cell Survival
Cells, Cultured
Cells, Cultured
Culture Media
Culture Media
Dose-Response Relationship, Drug
Dose-Response Relationship, Drug
Drug Delivery Systems
Drug Delivery Systems
Electrophoresis, Polyacrylamide Gel
Electrophoresis, Polyacrylamide Gel
Female
Female
Humans
Humans
Methionine
Methionine
Plasmids
Plasmids
Receptors, Cell Surface
Receptors, Cell Surface
Receptors, Urokinase Plasminogen Activator
Receptors, Urokinase Plasminogen Activator
Recombinant Fusion Proteins
Recombinant Fusion Proteins
authors with profiles
Roger G Harrison